The Faster Way to Turn $200 into $3,000

Why the Supreme Cannabis Company Inc (TSX:FIRE) is the only cannabis stock rising during the bear market.

Financial technology concept.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

With one exception, overpriced cannabis stocks have failed to impress investors on the Toronto Stock Exchange (TSX) during the bear market selloff. Supreme Cannabis Company (TSX:FIRE) climbed 18% this week to $1.42 per share. The outstanding price-performance coincides with an exciting acquisition announcement and record-breaking earnings guidance.

Don’t let the fear-induced selloffs scare you away from investing and look for solid buy opportunities. As Warren Buffett says, “Be fearful when others are greedy and greedy when others are fearful.” Bear markets are great for separating suitable investments from the bad. Price appreciation during a market selloff is a good sign that a stock may be undervalued or less risky than its peers.

In the case of Supreme Cannabis, it is proving itself to be a real competitor post-legalization. Neptune Wellness and The Green Organic Dutchman have struggled to demonstrate sales and revenue growth following marijuana legalization in Canada. Supreme Cannabis earnings paint a much brighter picture of the profit opportunities in this industry.

I don’t typically like recommending stocks that don’t offer a dividend to serious investors, but Supreme Cannabis is an exception. Given the reliable earnings guidance and the low price, I believe investors should snap up at least 100 shares and not worry about the risk. A $200 investment in Supreme Cannabis today could easily be worth $3,000 tomorrow.

Competitive earnings announcement

On Wednesday, as other cannabis stocks were struggling to excite investors during quarterly earnings calls, Supreme Cannabis brilliantly timed an earnings guidance announcement. The under-the-radar cannabis stock expects to report a 449% increase in revenue on September 17, 2019, for the quarter ended June 30.

Moreover, Supreme Cannabis also expects positive net income for the fourth quarter and record yearly performance. These figures demonstrate that the company can compete in the global cannabis marketplace. Next year should see outstanding revenue growth as Supreme Cannabis scales its production and introduces new, higher-margin products brands.

Truverra acquisition grabs attention

Shareholders were excited to hear that Supreme Cannabis acquired a new subsidiary with international reach. Truverra operates an e-commerce store throughout Europe. Cannabis is a high margin product as is, and cutting out the margin depletion of expensive retail operations augments the industry’s profit potential.

Experienced investors are taking the cost of sales per gram seriously in the cannabis space. Especially in the Canadian market, high costs to cultivate, produce, and distribute cannabis are taking front stage as investors separate the cannabis winners from the losers. A new e-commerce platform tells investors that Supreme Cannabis is a real competitor in the race to build the world’s top cannabis empire.

At below $2.00 per share, value investors are excited to see that a top contender is still underpriced.

Foolish takeaway

Cannabis markets are snowballing, which means that investors still have an opportunity to profit from the newly legal industry. Fortunately, there are still underpriced cannabis stocks which have largely avoided the speculative runs in price as day traders gamble on short-squeezes.

Supreme Cannabis is one of these stocks. Although it doesn’t offer a dividend like the insurance and banking industries, long-term investors should consider adding this stock to their portfolio. An investment of under $1,000 in this stock can quickly return over 1,500% in the next year with minimal downside risk!

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Debra Ray has no position in any of the stocks mentioned. 

More on Cannabis Stocks

Cannabis smoke
Cannabis Stocks

Canopy Growth Stock: Is Now a Good Time to Invest?

The road ahead is highly uncertain for Canopy Growth, as the stock is plagued with losses and seemingly unsurmountable industry…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

TLRY Stock: Should You Invest Now?

TLRY is a Canadian cannabis stock which is trading 91% below record highs. Let's see if you should own TLRY…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Tilray Stock a Buy in February 2023?

Despite the volatile cannabis sector, Tilray could be a superb buy for long-term investors.

Read more »

Young woman sat at laptop by a window
Cannabis Stocks

Is SNDL Stock a Buy in February 2023?

SNDL is a beaten-down cannabis stock. While its revenue growth is exceptional, a weak balance sheet has driven stock prices…

Read more »

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »